Menu

MNJ Institute of Oncology & Regional Cancer Centre

Claim This Site

Are you the site administrator? Claim this site to update information.

8Total Trials
1Recruiting Trials
3Active Trials
4Completed Trials
15Unique Conditions
11Unique Sponsors

Conditions

Adenocarcinoma (1)Breast Neoplasms (1)Esophageal Adenocarcinoma (1)Fallopian Tube Neoplasms (1)Gastric Neoplasms (1)Gastroesophageal Adenocarcinoma (1)Gastrointestinal Neoplasms (1)Head and Neck Neoplasms (1)

Sponsors

Aurigene Discovery Technologies Limited (1)Bayer (1)BeOne Medicines LTD (1)BeOne Pharmaceutical Co., Ltd. (1)Boehringer Ingelheim (1)CanariaBio Inc. (1)Eisai Inc. (1)Imugene Limited (1)

Affiliations

Basic Information

Site Overview

MNJ Institute of Oncology & Regional Cancer Centre (MNJIO&RCC) is a major government cancer centre in Hyderabad with a strong focus on oncology care, research and academic activities. From a clinical research perspective, the institute provides access to a large and diverse oncology patient population and has multidisciplinary expertise across Medical Oncology, Surgical Oncology, Radiation Oncology, Pediatric Oncology, Gynecologic Oncology and other cancer specialties. Its diagnostic, pathology, molecular and imaging infrastructure can support clinical research activities, including oncology clinical trials, patient screening, treatment evaluation, sample-based research and long-term follow-up. The institute’s role as a regional referral centre makes it a potentially valuable site for investigator-initiated and industry-sponsored oncology research, particularly studies involving diverse cancer types and treatment modalities.

Business Status

OPEN

Business Category

location

Trial Phases

Historical Trial Phase Experience

Phase I
Phase II
Phase IV
Phase III

Research Team & Staffing

Research team size (total staff)

3

Principal investigators

6

Study coordinators

7